APACT Study in Pancreatic Adenocarcinoma Details

Vincent Chung MD, Associate Clinical Professor and Medical Oncologist at City of Hope discusses details from APACT study, a phase III trial of adjuvant nab-paclitaxel plus gemcitabine.